Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Messina

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Brain : a Journal of Neurology|May 8, 2007
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathiesHaiyan Zhou, Heinz Jungbluth, Caroline A Sewry, et al.
Sleep Medicine|February 21, 2017
Sleep disorders in spinal muscular atrophyMaria C Pera, Domenico M Romeo, Alessandra Graziano, et al.
Neuromuscular Disorders : NMD|March 28, 2021
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measureValeria A Sansone, Alice Pirola, Andrea Lizio, et al.
Children (Basel, Switzerland)|May 16, 2023
Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month StudyClaudia Brogna, Marika Pane, Giorgia Coratti, et al.
Plos One|October 30, 2015
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated CardiomyopathyAndrea Barp, Luca Bello, Luisa Politano, et al.
Annals of Neurology|June 23, 2019
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world dataMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Journal of Medical Genetics|December 30, 2018
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamolFrancesco Danilo Tiziano, Rosa Lomastro, Emanuela Abiusi, et al.
European Journal of Pediatrics|January 20, 2022
Body mass index in type 2 spinal muscular atrophy: a longitudinal studyGloria Ferrantini, Giorgia Coratti, Roberta Onesimo, et al.
The Journal of Pediatrics|February 10, 2020
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with NusinersenValeria A Sansone, Alice Pirola, Emilio Albamonte, et al.
European Journal of Human Genetics : EJHG|October 18, 2012
Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker studyFrancesco D Tiziano, Rosa Lomastro, Lorena Di Pietro, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Brain : a Journal of Neurology|May 8, 2007
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathiesHaiyan Zhou, Heinz Jungbluth, Caroline A Sewry, et al.
Sleep Medicine|February 21, 2017
Sleep disorders in spinal muscular atrophyMaria C Pera, Domenico M Romeo, Alessandra Graziano, et al.
Neuromuscular Disorders : NMD|March 28, 2021
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measureValeria A Sansone, Alice Pirola, Andrea Lizio, et al.
Children (Basel, Switzerland)|May 16, 2023
Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month StudyClaudia Brogna, Marika Pane, Giorgia Coratti, et al.
Plos One|October 30, 2015
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated CardiomyopathyAndrea Barp, Luca Bello, Luisa Politano, et al.
Annals of Neurology|June 23, 2019
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world dataMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Journal of Medical Genetics|December 30, 2018
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamolFrancesco Danilo Tiziano, Rosa Lomastro, Emanuela Abiusi, et al.
European Journal of Pediatrics|January 20, 2022
Body mass index in type 2 spinal muscular atrophy: a longitudinal studyGloria Ferrantini, Giorgia Coratti, Roberta Onesimo, et al.
The Journal of Pediatrics|February 10, 2020
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with NusinersenValeria A Sansone, Alice Pirola, Emilio Albamonte, et al.
European Journal of Human Genetics : EJHG|October 18, 2012
Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker studyFrancesco D Tiziano, Rosa Lomastro, Lorena Di Pietro, et al.
Pageof 17